Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Amerise Biosciences Ltd Fundamentals

Market Cap
₹ 4.1 Cr
P/E Ratio (TTM)
0.00
P/B Ratio
0.76
Debt to Equity
0.02
ROE
0.00
EPS (TTM)
0.00
Dividend Yield
0.00 %
Book Value
0.82

Click here to know more about Fundamentals

Amerise Biosciences Ltd Financials

Amerise Biosciences Ltd Financials

Amerise Biosciences Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Retail 72.32 % 72.33 % 72.44 % 72.37 %
Others 27.68 % 27.67 % 27.56 % 27.63 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Promoters 0.00 % 0.00 % 0.00 % 0.00 %

Retail

72.32%

Others

27.68%

Mutual Funds

0.00%

FII

0.00%

Promoters

0.00%

Retail

72.33%

Others

27.67%

Mutual Funds

0.00%

FII

0.00%

Promoters

0.00%

Retail

72.44%

Others

27.56%

Mutual Funds

0.00%

FII

0.00%

Promoters

0.00%

Retail

72.37%

Others

27.63%

Mutual Funds

0.00%

FII

0.00%

Promoters

0.00%

Resistance and Support

₹0.62

PIVOT

resistance-arrow
Resistance
First Resistance₹0.620
Second Resistance₹0.620
Third Resistance₹0.620
support-arrow
Support
First Support₹0.620
Second Support₹0.620
Third Support₹0.620

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day192192100.00
Week19254,3560.00
1 Month19265,7710.00
6 Months15,362,08114,317,28393.45

About Amerise Biosciences Ltd

Amerise Biosciences Limited (Formerly known Amradeep Industries Limited) was incorporated in 1984 by a private Indian party, as a specialized manufacturer of high quality construction equipment and agricultural equipment. On October 29, 2002 the name of the Company was changed from Amstar Laminates Limited to Amardeep Industries Limited and further to Amerise Biosciences Limited in August, 2021. Initially, the Company was engaged into the business of commodity trading. During the financial year 2007 it entered into the trading of castor seeds. As of now the Company is not engaged in any activity and the management is looking for a right opportunity to make the Company operational. Due to scarcity of working capital funds, the Company is not able to perform any business activities. To make the Company operational, the Board is implementing the cost reduction measures to the extent feasible.

Managing Director

1984

Founded

NA

NSE Symbol

NA

Amerise Biosciences Ltd Management

NameDesignation
Manisha Maneklal PatelIndependent Director
Dineshkumar Tribhovanbhai RathodWhole-time Director
Minal LakhlaniCompany Sec. & Compli. Officer
Niraj VaghelaIndependent Director

Amerise Biosciences Ltd News

Amerise Biosciences to announce Quarterly Result
On 23 May 2024
Amerise Biosciences reports standalone net loss of Rs 0.06 crore in the December 2023 quarter
Reported sales nil
Amerise Biosciences schedules board meeting
On 22 January 2024
Amerise Biosciences reports standalone net loss of Rs 0.04 crore in the September 2023 quarter
Reported sales nil
Amerise Biosciences to hold board meeting
On 7 November 2023
Amerise Biosciences to hold AGM
On 26 September 2023
Amerise Biosciences reports standalone net loss of Rs 0.07 crore in the June 2023 quarter
Reported sales nil
Amerise Biosciences to hold board meeting
On 8 August 2023
Amerise Biosciences reports standalone net loss of Rs 0.02 crore in the March 2023 quarter
Reported sales nil
Amerise Biosciences schedules board meeting
On 4 May 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
Bajaj Finance Ltd₹ 417079.72 Cr
₹ 6,738.00
(0.16 %)
32.97
Bajaj Finserv Ltd₹ 253283.85 Cr
₹ 1,587.50
(0.17 %)
216.41
Jio Financial Services Ltd₹ 230115.95 Cr
₹ 362.20
(1.40 %)
0.00
Indian Railway Finance Corporation Ltd₹ 226411.87 Cr
₹ 173.25
(2.51 %)
37.49
Power Finance Corporation Ltd₹ 153768.24 Cr
₹ 465.95
(-0.46 %)
10.70

Amerise Biosciences Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Amerise Biosciences Ltd shares in BlinkX

Amerise Biosciences Ltd's P/E ratio is 0.00 times as of May 18, 2024 at 04:00 PM.

Amerise Biosciences Ltd's most recent financial reports indicate a price-to-book ratio of 0.76, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Amerise Biosciences Ltd's market is 4 Cr as on May 18, 2024 at 04:00 PM.

The current financial records of Amerise Biosciences Ltd show a 0.00% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

According to Amerise Biosciences Ltd's most recent financial filings, the company has a total asset value of Crores, which includes current and non-current assets such as inventory, cash, properties, and equipment.

As of the Mar 2024 quarter, the promoter shareholding in Amerise Biosciences Ltd stands at 0.00%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.